Temsirolimus bulk supplier for pharma manufacturers

Temsirolimus 25 mg/ml, 100 mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 25 mg/ml, 100 mg

Reference Brands: Torisel (USA)

Temsirolimus is a Oncology Cancer Care product available as Injection in strengths 25 mg/ml, 100 mg. It corresponds to the reference brand Torisel (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Temsirolimus? List it or send an offer →

Product Description:

Temsirolimus is an intravenous anticancer medication sold under the brand name Torisel and is primarily used for the treatment of advanced renal cell carcinoma (RCC). It is a derivative and prodrug of sirolimus and works by inhibiting the mammalian target of rapamycin (mTOR), a key protein kinase that regulates cell growth, proliferation, metabolism, and angiogenesis. By blocking mTOR signaling, temsirolimus slows the growth and division of cancer cells and helps reduce tumor progression.

Developed by Wyeth Pharmaceuticals, temsirolimus was approved by the U.S. Food and Drug Administration (FDA) in May 2007 and by the European Medicines Agency (EMA) in November 2007. It is administered intravenously under medical supervision, typically in patients with advanced or poor-risk RCC. Temsirolimus provides a targeted therapeutic option for patients who may not be suitable for surgical interventions, offering a mechanism-based approach to controlling tumor growth.

Temsirolimus — third party manufacturing & bulk supply

Temsirolimus 25 mg/ml, 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Temsirolimus is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Temsirolimus listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Temsirolimus →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing